GENinCode (GENI)

Sector:

Health Care

Index:

FTSE AIM All-Share

2.33p
   
  • Change Today:
      0.083p
  • 52 Week High: 7.75
  • 52 Week Low: 1.40
  • Currency: UK Pounds
  • Shares Issued: 286.88m
  • Volume: 0
  • Market Cap: £6.69m

Deal with Barclays    Trade now with Barclays Stockbrokers

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
64.65% above the market average64.65% above the market average64.65% above the market average64.65% above the market average64.65% above the market average
29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
1.34% above the market average1.34% above the market average1.34% above the market average1.34% above the market average1.34% above the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average
Price Book Ratio
83.62% below the market average83.62% below the market average83.62% below the market average83.62% below the market average83.62% below the market average
87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
93.96% above the market average93.96% above the market average93.96% above the market average93.96% above the market average93.96% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Chg 3m
87.25% below the market average87.25% below the market average87.25% below the market average87.25% below the market average87.25% below the market average
72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
72.43% above the market average72.43% above the market average72.43% above the market average72.43% above the market average72.43% above the market average
81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average
Momentum 20
8.10% above the market average8.10% above the market average8.10% above the market average8.10% above the market average8.10% above the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
82.32% below the market average82.32% below the market average82.32% below the market average82.32% below the market average82.32% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
70.62% below the market average70.62% below the market average70.62% below the market average70.62% below the market average70.62% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
68.07% below the market average68.07% below the market average68.07% below the market average68.07% below the market average68.07% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average
Operating Profit Loss
76.79% below the market average76.79% below the market average76.79% below the market average76.79% below the market average76.79% below the market average
51.52% below the sector average51.52% below the sector average51.52% below the sector average51.52% below the sector average51.52% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
71.85% below the market average71.85% below the market average71.85% below the market average71.85% below the market average71.85% below the market average
93.94% below the sector average93.94% below the sector average93.94% below the sector average93.94% below the sector average93.94% below the sector average
Cash
55.42% below the market average55.42% below the market average55.42% below the market average55.42% below the market average55.42% below the market average
75.76% below the sector average75.76% below the sector average75.76% below the sector average75.76% below the sector average75.76% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

GENinCode Market Data

Currency UK Pounds
Share Price 2.33p
Change Today 0.083p
% Change 3.70 %
52 Week High 7.75
52 Week Low 1.40
Volume 0
Shares Issued 286.88m
Market Cap £6.69m

GENinCode Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.19% below the market average68.19% below the market average68.19% below the market average68.19% below the market average68.19% below the market average
15.15% below the sector average15.15% below the sector average15.15% below the sector average15.15% below the sector average15.15% below the sector average
Price Trend
91.63% below the market average91.63% below the market average91.63% below the market average91.63% below the market average91.63% below the market average
83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average
Income Not Available
Growth
46.77% above the market average46.77% above the market average46.77% above the market average46.77% above the market average46.77% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average

GENinCode Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

GENinCode Key Personnel

CEO Matthew Heaton Walls
CFO Paul Andrew Peter Foulger
COO Jordi Puig Gilberte

Top of Page